171099-57-3 (奥利万星,Vancomycin,22-O-(3-amino-2,3,6-trideoxy-3-C-methyl-a-L-arabino-hexopyranosyl)-N3''-[(4'-chloro[1,1'-biphenyl]-4-yl)methyl]-,(4''R)-)

奥利万星;奥利万星磷酸盐;ORITAVANCIN奥利万星;

Vancomycin,22-O-(3-amino-2,3,6-trideoxy-3-C-methyl-a-L-arabino-hexopyranosyl)-N3''-[(4'-chloro[1,1'-biphenyl]-4-yl)methyl]-,(4''R)-;ORITAVANCIN;Vancomycin,22-O-(3-amino-2,3,6-trideoxy-3-C-methyl-a-L-arabino-hexopyranosyl)-N3''-[(4'-chloro[1,1'-biphenyl]-4-yl)methyl]-,(;(4''R)-22-O-(3-Amino-2,3,6-trideoxy-3-C-methyl-alpha-L-arabino-hexopyranosyl)-N3''-[(4'-chloro[1,1'-biphenyl]-4-yl)methyl]vancomycin;LY 333328;Orbactiv;Oritavancin (LY333328);Oritavancin (Lyophilized Powder For IV Infusion);(4R)-22-O-(3-Amino-2,3,6-trideoxy-3-C-methyl-a-L-arabinohexopyranosyl)-N3-(p-(p-chlorophenyl)benzyl)vancomycin;(1S,2R,18R,19R,22S,25R,28R,40R)-22-(2-Amino-2-oxoethyl)-2-[(3-amino-2,3,6-trideoxy-3-methyl-α-L-arabino-hexopyranosyl)oxy]-5,15-dichloro-48-{[2-O-(3-{[(4'-chloro-4-biphenylyl)methyl]amino}-2,3,6-t;(4''R)-22-O-(3-Amino-2,3,6-trideoxy-3-C-methyl-alpha-L-arabinohexopyranosyl)-N3''-(p-(p-chlorophenyl)benzyl)vancomycin;(4''R)-22-O-(3-AMINO-2,3,6-TRIDEOXY-3-C-METHYL-.ALPHA.-L-ARABINO-HEXOPYRANOSYL)-N(SUP 3)''-(P-(P-CHLOROPHENYL)BENZYL)VANCOMYCIN;oritavancina;VANCOMYCIN, 22-O-(3-AMINO-2,3,6-TRIDEOXY-3-C-METHYL-.ALPHA.-L-ARABINO-HEXOPYRANOSYL)-N3''-((4'-CHLORO(1,1'-BIPHENYL)-4-YL)METHYL)-, (4''R)-;Oritavancin; LY-333328;UNII-PUG62FRZ2E;ORITAVANCIN [MART.];oritavancinum;ORITAVANCIN [MI];oritavancine;Chlorobiphenyl-chloroeremomycin;Orita-vancin;C12034;BDBM513037;PUG62FRZ2E;(4''R)-22-O-(3-AMINO-2,3,6-TRIDEOXY-3-C-METHYL-alpha-L-ARABINO-HEXOPYRANOSYL)-N(SUP 3)''-(P-(P-CHLOROPHENYL)BENZYL)VANCOMYCIN;ORITAVANCIN (MART.);171099-57-3;LY-333328;LY333328;J01XA05;NCGC00485478-01;CHEBI:82699;(4''R)-22-O-(3-amino-2,3,6-trideoxy-3-C-methyl-alpha-L-arabino-hexopyranosyl)-N(3'')-((4'-chloro(1,1'-biphenyl)-4-yl)methyl)vancomycin;EX-A2372;AKOS032944863;DTXCID701326917;VHFGEBVPHAGQPI-LXKZPTCJSA-N;Q7102878;GTPL10877;CHEMBL1688530;Oritavancin(LY-333328);ORITAVANCIN [VANDF];VANCOMYCIN, 22-O-(3-AMINO-2,3,6-TRIDEOXY-3-C-METHYL-alpha-L-ARABINO-HEXOPYRANOSYL)-N3''-((4'-CHLORO(1,1'-BIPHENYL)-4-YL)METHYL)-, (4''R)-;(4'R)-22-O-(3-Amino-2,3,6-trideoxy-3-C-methyl-alpha-L-arabino-hexopyranosyl)-N(sup 3)' -(p-(p-chlorophenyl)benzyl)vancomycin;SCHEMBL9947049;DB04911;NCGC00485478-02;ORITAVANCIN [WHO-DD];Oritavancin [INN];DTXSID20897570;rideoxy-3-methyl-α-L-arabino-hexopyranosyl)-β-D-g;GLXC-10720;DA-66365;

VHFGEBVPHAGQPI-LXKZPTCJSA-N

1S/C86H97Cl3N10O26/c1-35(2)22-51(92-7)77(110)98-67-69(105)42-15-20-55(49(88)24-42)120-57-26-44-27-58(73(57)125-84-74(71(107)70(106)59(34-100)122-84)124-62-32-86(6,76(109)37(4)119-62)93-33-38-8-10-39(11-9-38)40-12-17-45(87)18-13-40)121-56-21-16-43(25-50(56)89)72(123-61-31-85(5,91)75(108)36(3)118-61)68-82(115)97-66(83(116)117)48-28-46(101)29-54(103)63(48)47-23-41(14-19-53(47)102)64(79(112)99-68)96-80(113)65(44)95-78(111)52(30-60(90)104)94-81(67)114/h8-21,23-29,35-37,51-52,59,61-62,64-72,74-76,84,92-93,100-103,105-109H,22,30-34,91H2,1-7H3,(H2,90,104)(H,94,114)(H,95,111)(H,96,113)(H,97,115)(H,98,110)(H,99,112)(H,116,117)/t36-,37-,51+,52-,59+,61-,62-,64+,65+,66-,67+,68-,69+,70+,71-,72+,74+,75-,76-,84-,85-,86-/m0/s1

ClC1=C2C=CC(=C1)[C@H]([C@H]1C(N[C@H](C(=O)O)C3C=C(C=C(C=3C3=C(C=CC(=C3)[C@H](C(N1)=O)NC([C@H]1C3=CC(=C(C(=C3)O2)O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](CO)O2)O)O)O[C@H]2C[C@@](C)([C@H]([C@H](C)O2)O)NCC2C=CC(C3C=CC(=CC=3)Cl)=CC=2)OC2C=CC([C@H]([C@H](C(N[C@@H](CC(N)=O)C(N1)=O)=O)NC([C@@H](CC(C)C)NC)=O)O)=CC=2Cl)=O)O)O)O)=O)O[C@H]1C[C@@](C)([C@H]([C@H](C)O1)O)N